Pamplona Capital Management (“Pamplona”) has just acquired Loparex from funds managed by Intermediate Capital group (“ICG”), alongside members of the company’s leadership team, who remain committed to supporting the long-term growth of Loparex’s customers. Simon Medley will continue to serve as the CEO.
Loparex has been serving customers in a diverse range of technically demanding end markets, including medical, industrial, tapes, graphics, hygiene, label and composites. Loparex has a global presence, with operations in North America, Europe and Asia.
Paul MacDuff, Partner at Pamplona, said: “Over the last 113 years, Loparex has established itself as a leader in the silicone release liners market, with a strong reputation for in-depth technical expertise and industry-leading production technology. We look forward to working with the Loparex management team to solidify and build on this position going forward.”
Simon Medley, Loparex CEO, commented: “Loparex is well placed for future growth and we firmly believe that Pamplona is the right partner to support us as we accelerate our market-driven strategy to create significant value for both the company and its customers.”
Martin Schwab and William Pruellage, Co-Managing Partners at Pamplona, added: “Pamplona has a proven track record in accelerating the development and expansion of manufacturing companies, and we are looking forward to bringing the company’s expertise and products to an even wider global market.”
The investment of Pamplona has been made from its fifth private equity fund, Pamplona Capital Partners V, L.P., a $3.2 billion investment vehicle raised in 2017.